Related Experiment Video
Updated: Jun 8, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Internists' deprescribing behavior for proton pump inhibitor therapy: a qualitative study based on the theoretical
Beyza Nur Ataoğlu1, Betul Okuyan2, Rabia Yaren Şahin3
1Faculty of Medicine, Public Health Department, Marmara University, İstanbul, Türkiye. beyzanur.ataoglu@saglik.gov.tr.
Background:
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. However, they are often used inappropriately and may cause adverse effects in long-term use. This study aimed to explore internists' beliefs, attitudes and behaviors regarding deprescribing PPIs in Türkiye, by using the Theoretical Domains Framework (TDF).
Methods:
This qualitative study was conducted at a university hospital in Türkiye. Data were collected through face-to-face, in-depth interviews conducted in March-April 2023. The participants were selected through convenience sampling from among the residents and specialists working in the internal medicine department. A semi-structured interview guide, including two vignettes, was used. The data were evaluated using thematic analysis in Atlas.ti program.
Results:
A total of 12 participants (10 residents and two specialists) participated in the study. Internists' behaviors related to deprescribing were mapped to 12 TDF domains including barriers (environmental context and resources, reinforcement, social influences, optimism/pessimism and emotions, social/professional role and identity, and knowledge and skills, beliefs about consequences) and enablers (intention and goals, memory, attention, and decision-making processes, beliefs about consequences). Despite the challenges posed by a fragmented healthcare system, heavy workload, poor coordination among providers, and patients' strong expectations of PPIs as "rescue" drugs, the participants still expressed an intention to deprescribe.
Conclusions:
This study highlights the need for systemic changes to improve deprescribing practices for PPIs in Türkiye. To promote deprescribing, appropriate behavior change techniques and implementation strategies should be identified and evaluated to ensure integrated care, evidence-based guidelines, and patient-centered practice.
Clinical Trial Number:
Not Applicable.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drug Dosing: Geriatric Patients
Antidepressant Drugs: MAOIs and Other Agents
Drug Abuse and Addiction: Pharmacological Phenomena
Acute Coronary Syndrome IV: Interprofessional Care
